Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 1:32 PM ET


Company Overview of Critical Biologics Corporation

Executive Profile

James W. Fordyce

Co-Founder and Chairman, Critical Biologics Corporation
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships


Mr. James W. Fordyce, also known as Jim is a Managing Partner at MEDNA Partners LLC. Mr. Fordyce serves as Chief Financial Officer and Executive Vice President of Lotus Tissue Repair, Inc. He is a General Partner of Prince Venture Partners I, LP. Mr. Fordyce serves as an Advisor at Darwin Ventures, LLC. He is Owner and General Partner of p-Value Capital. He Co-founded Critical Biologics Corporation in 2004. Mr. Fordyce has over 25 years of private equity investment experience ...

Corporate Headquarters

One Mifflin Place
Cambridge, Massachusetts 02138

United States

Phone: 908-439-9768
Fax: 908-439-9768

Board Members Memberships

Chairman Emeritus
Co-Founder and Chairman
Chairman, Executive Vice President and Chief Financial officer
Director, Member of Audit Committee and Member of Nominating & Governance Committee


MBA 1970
Harvard Business School
Unknown/Other Education 1964
The University of Pennsylvania
Unknown/Other Education 1967
Magdalen College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Critical Biologics Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at